<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03065036</url>
  </required_header>
  <id_info>
    <org_study_id>CP-09-001</org_study_id>
    <secondary_id>HYDRUS I</secondary_id>
    <nct_id>NCT03065036</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy Study of the Hydrus Aqueous Implant in Subjects With POAG</brief_title>
  <acronym>POAG</acronym>
  <official_title>A Prospective, Multi-Center Evaluation of the Hydrus Aqueous Implant (Standard and Low-Profile) for Lowering Intraocular Pressure (IOP) in Subjects With Mild to Advanced Primary Open Angle Glaucoma (POAG) With or Without a Cataract</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ivantis, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ivantis, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the ocular hypotensive effect of the Hydrus Aqueous
      Implant (Standard and Low-Profile), as determined by the change in IOP from baseline
      (preoperative) and change in the number of glaucoma medications from baseline.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, multi-center study that will examine subjects with documented mild to
      advanced primary open angle glaucoma (POAG), who may or may not have a cataract requiring
      removal and placement of an intraocular lens.

      Study subjects will be grouped by the severity of their disease (either mild/moderate or
      advanced). If all inclusion and exclusion criteria are met subjects in all four groups will
      be implanted with the Hydrus Aqueous Implant. Subjects in whom a cataract is present will
      undergo standard cataract removal and IOL implantation concurrent with implantation of the
      Hydrus.

      Postoperatively, subjects will undergo a complete ophthalmic evaluation at regularly
      scheduled intervals.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 2010</start_date>
  <completion_date type="Actual">February 2014</completion_date>
  <primary_completion_date type="Actual">November 2013</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in IOP of study eye between each randomized group</measure>
    <time_frame>Baseline &amp; One year</time_frame>
    <description>Effectiveness will be determined by comparing the IOP at the baseline (pre-operative) visit to the the IOP at the 12 month post-operative visit.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in glaucoma medications</measure>
    <time_frame>Baseline &amp; One year</time_frame>
    <description>Calculate the change in the number of glaucoma medications from baseline (pre-operative) visit to the 12-month post-operative visit.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Primary Open Angle Glaucoma</condition>
  <arm_group>
    <arm_group_label>Hydrus Aqueous Implant</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Hydrus implanted into Schlemm's Canal.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IOL placement and Hydrus implant</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Cataract Extraction with IOL placement and Hydrus implant into Schlemm's canal</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>prestudy topical glaucoma medications</intervention_name>
    <description>Reintroduction of prestudy topical glaucoma medications, introduced one medication at a time during each study visit, as necessary.</description>
    <arm_group_label>Hydrus Aqueous Implant</arm_group_label>
    <arm_group_label>IOL placement and Hydrus implant</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Elevated intraocular pressure (IOP)

          -  Diagnosis of mild to advanced open-angle glaucoma

          -  Shaffer Grade III

          -  Mental capacity to cooperate when undergoing operative and postoperative examination

          -  18 years of age or older

          -  Provide written informed consent

          -  Willing and able to return to scheduled follow-up examinations for 24-months

        Exclusion Criteria:

          -  Closed-angle and narrow-angle forms of glaucoma

          -  Secondary glaucomas

          -  Congenital or developmental glaucoma
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Prof. Dr. Manfred Tetz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Augentagesklinik Spreebogen Berlin</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Medical Center Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>A-1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aurelios Augenzentrum</name>
      <address>
        <city>Recklinghausen</city>
        <state>Erlbruch</state>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Berlin</city>
        <zip>10559</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitatsmedizin der Johannes Gutenberg-Universitat Mainz Augenklinik und Poliklinik</name>
      <address>
        <city>Mainz</city>
        <zip>55131</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tijuana</city>
        <state>Baja California</state>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Germany</country>
    <country>Mexico</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 29, 2012</study_first_submitted>
  <study_first_submitted_qc>February 22, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">February 27, 2017</study_first_posted>
  <last_update_submitted>April 4, 2018</last_update_submitted>
  <last_update_submitted_qc>April 4, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 6, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Primary Open Angle Glaucoma</keyword>
  <keyword>POAG</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
    <mesh_term>Glaucoma, Open-Angle</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

